Bank of New York Mellon’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $51.6M | Buy |
328,948
+1,131
| +0.3% | +$170K | 0.01% | 1050 |
|
|
2026
Q1 | $50.1M | Buy |
327,817
+9,691
| +3% | +$1.49M | 0.01% | 999 |
|
|
2025
Q4 | $43.9M | Buy |
318,126
+5,758
| +2% | +$754K | 0.01% | 1079 |
|
|
2025
Q3 | $40.1M | Sell |
312,368
-3,992
| -1% | -$487K | 0.01% | 1156 |
|
|
2025
Q2 | $38.3M | Sell |
316,360
-225,937
| -42% | -$25.5M | 0.01% | 1161 |
|
|
2025
Q1 | $60.5M | Sell |
542,297
-168,948
| -24% | -$18M | 0.01% | 844 |
|
|
2024
Q4 | $69.2M | Sell |
711,245
-49,388
| -6% | -$5.27M | 0.01% | 819 |
|
|
2024
Q3 | $87.5M | Sell |
760,633
-1,144,031
| -60% | -$130M | 0.02% | 717 |
|
|
2024
Q2 | $203M | Buy |
1,904,664
+1,250,318
| +191% | +$126M | 0.04% | 373 |
|
|
2024
Q1 | $63.3M | Buy |
654,346
+29,491
| +5% | +$3.02M | 0.01% | 906 |
|
|
2023
Q4 | $63.1M | Buy |
624,855
+3,536
| +0.6% | +$341K | 0.01% | 900 |
|
|
2023
Q3 | $63.3M | Sell |
621,319
-3,836
| -0.6% | -$389K | 0.01% | 852 |
|
|
2023
Q2 | $63.1M | Sell |
625,155
-93
| -0% | -$9.3K | 0.01% | 879 |
|
|
2023
Q1 | $57.5M | Sell |
625,248
-64,967
| -9% | -$5.67M | 0.01% | 920 |
|
|
2022
Q4 | $62.6M | Buy |
690,215
+23,772
| +4% | +$2M | 0.01% | 855 |
|
|
2022
Q3 | $50.7M | Sell |
666,443
-98,241
| -13% | -$8.14M | 0.01% | 950 |
|
|
2022
Q2 | $64.6M | Sell |
764,684
-11,105
| -1% | -$974K | 0.01% | 824 |
|
|
2022
Q1 | $68.1M | Buy |
775,789
+35,370
| +5% | +$3.06M | 0.01% | 888 |
|
|
2021
Q4 | $64.8M | Buy |
740,419
+51,360
| +7% | +$4.26M | 0.01% | 972 |
|
|
2021
Q3 | $56.4M | Buy |
689,059
+42,795
| +7% | +$3.85M | 0.01% | 1056 |
|
|
2021
Q2 | $59M | Buy |
646,264
+22,588
| +4% | +$2.01M | 0.01% | 1033 |
|
|
2021
Q1 | $53.3M | Buy |
623,676
+8,054
| +1% | +$723K | 0.01% | 1072 |
|
|
2020
Q4 | $58.1M | Sell |
615,622
-16,924
| -3% | -$1.48M | 0.01% | 959 |
|
|
2020
Q3 | $55M | Sell |
632,546
-15,536
| -2% | -$1.35M | 0.01% | 865 |
|
|
2020
Q2 | $56.6M | Sell |
648,082
-79,366
| -11% | -$6.85M | 0.02% | 810 |
|
|
2020
Q1 | $60M | Sell |
727,448
-33,671
| -4% | -$3M | 0.02% | 674 |
|
|
2019
Q4 | $72.1M | Buy |
761,119
+134,144
| +21% | +$12M | 0.02% | 762 |
|
|
2019
Q3 | $54.5M | Buy |
626,975
+20,101
| +3% | +$1.8M | 0.01% | 897 |
|
|
2019
Q2 | $55.4M | Sell |
606,874
-65,520
| -10% | -$5.55M | 0.02% | 912 |
|
|
2019
Q1 | $57.9M | Sell |
672,394
-42,756
| -6% | -$3.43M | 0.02% | 868 |
|
|
2018
Q4 | $55M | Buy |
715,150
+5,601
| +0.8% | +$436K | 0.02% | 814 |
|
|
2018
Q3 | $54.8M | Sell |
709,549
-56,291
| -7% | -$4.16M | 0.01% | 959 |
|
|
2018
Q2 | $51.8M | Sell |
765,840
-351,364
| -31% | -$24.2M | 0.01% | 981 |
|
|
2018
Q1 | $80.9M | Sell |
1,117,204
-45,757
| -4% | -$3.48M | 0.02% | 710 |
|
|
2017
Q4 | $87.5M | Sell |
1,162,961
-144
| -0% | -$10.9K | 0.02% | 705 |
|
|
2017
Q3 | $89.5M | Sell |
1,163,105
-3,087
| -0.3% | -$233K | 0.02% | 660 |
|
|
2017
Q2 | $87.2M | Sell |
1,166,192
-36,981
| -3% | -$2.62M | 0.02% | 647 |
|
|
2017
Q1 | $80.1M | Sell |
1,203,173
-72,476
| -6% | -$4.83M | 0.02% | 693 |
|
|
2016
Q4 | $83.3M | Sell |
1,275,649
-22,419
| -2% | -$1.45M | 0.02% | 640 |
|
|
2016
Q3 | $91.8M | Sell |
1,298,068
-56,768
| -4% | -$4.14M | 0.03% | 574 |
|
|
2016
Q2 | $100M | Buy |
1,354,836
+726
| +0.1% | +$50.2K | 0.03% | 525 |
|
|
2016
Q1 | $87.9M | Sell |
1,354,110
-37,655
| -3% | -$2.56M | 0.03% | 597 |
|
|
2015
Q4 | $107M | Sell |
1,391,765
-35,332
| -2% | -$2.81M | 0.03% | 503 |
|
|
2015
Q3 | $118M | Sell |
1,427,097
-267,847
| -16% | -$23.8M | 0.04% | 471 |
|
|
2015
Q2 | $149M | Sell |
1,694,944
-135,296
| -7% | -$12.4M | 0.04% | 429 |
|
|
2015
Q1 | $162M | Sell |
1,830,240
-344,222
| -16% | -$30.5M | 0.04% | 432 |
|
|
2014
Q4 | $181M | Buy |
2,174,462
+768,719
| +55% | +$63.7M | 0.05% | 393 |
|
|
2014
Q3 | $119M | Sell |
1,405,743
-19,743
| -1% | -$1.6M | 0.03% | 515 |
|
|
2014
Q2 | $116M | Sell |
1,425,486
-262,664
| -16% | -$20.7M | 0.03% | 528 |
|
|
2014
Q1 | $129M | Buy |
1,688,150
+212,666
| +14% | +$15.5M | 0.04% | 493 |
|
|
2013
Q4 | $106M | Sell |
1,475,484
-47,681
| -3% | -$3.31M | 0.03% | 552 |
|
|
2013
Q3 | $105M | Buy |
1,523,165
+356,939
| +31% | +$23.6M | 0.03% | 534 |
|
|
2013
Q2 | $73.9M | Buy |
+1,166,226
| New | +$75.9M | 0.02% | 653 |
|
Other funds holding NVS
NW
Bank of New York Mellon's NVS Position: Q2 2026 in Review
Bank of New York Mellon increased its Novartis (NVS) stake by 0.35% in Q2 2026, buying an estimated $170K and bringing the position to 328,948 shares worth $51.6M. The position accounts for 0.01% of the portfolio, ranked #1050.
Bank of New York Mellon first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $203M in Q2 2024. 1,246 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Bank of New York Mellon held 328,948 shares of Novartis worth $51.6M as of Q2 2026.
- Bank of New York Mellon bought 1,131 Novartis shares in Q2 2026, an estimated $170K.
- Novartis made up 0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1050 holding.
- Bank of New York Mellon first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Novartis position peaked at $203M in Q2 2024.
- 1,246 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.